NUVB
Nuvation Bio·NYSE
--
--(--)
--
--(--)
6.03 / 10
Outperform
Analyst coverage is uniformly bullish with two active analysts, both rating NUVB as Buy. Institutional sentiment is supportive, and medium/large fund flows exhibit positive trends, although overall flow is negative. This divergence suggests that while retail sentiment may be cooling, professional investors continue to lean in, providing a potential floor for the share price.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionWedbush
Times predicted5
Historical Win Rate60.0%
Is money flowing into or out of NUVB?
- NUVB holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.03/10 (Outperform).
